TW200719914A - Use of vascular endothelial growth factor receptor inhibitors for the treatment of gastrointestinal, genitourinary, lymphoid and pulmonary cancers - Google Patents
Use of vascular endothelial growth factor receptor inhibitors for the treatment of gastrointestinal, genitourinary, lymphoid and pulmonary cancersInfo
- Publication number
- TW200719914A TW200719914A TW095113028A TW95113028A TW200719914A TW 200719914 A TW200719914 A TW 200719914A TW 095113028 A TW095113028 A TW 095113028A TW 95113028 A TW95113028 A TW 95113028A TW 200719914 A TW200719914 A TW 200719914A
- Authority
- TW
- Taiwan
- Prior art keywords
- genitourinary
- lymphoid
- gastrointestinal
- treatment
- growth factor
- Prior art date
Links
- 230000002496 gastric effect Effects 0.000 title abstract 2
- 206010017993 Gastrointestinal neoplasms Diseases 0.000 title 1
- 206010025323 Lymphomas Diseases 0.000 title 1
- 208000008385 Urogenital Neoplasms Diseases 0.000 title 1
- 229940127538 Vascular Endothelial Growth Factor Receptor Inhibitors Drugs 0.000 title 1
- 208000020816 lung neoplasm Diseases 0.000 title 1
- 206010028980 Neoplasm Diseases 0.000 abstract 2
- 229940124674 VEGF-R inhibitor Drugs 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 238000002512 chemotherapy Methods 0.000 abstract 1
- 210000000933 neural crest Anatomy 0.000 abstract 1
- 230000002685 pulmonary effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US67087005P | 2005-04-13 | 2005-04-13 | |
| US68039605P | 2005-05-12 | 2005-05-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW200719914A true TW200719914A (en) | 2007-06-01 |
Family
ID=36649704
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW095113028A TW200719914A (en) | 2005-04-13 | 2006-04-12 | Use of vascular endothelial growth factor receptor inhibitors for the treatment of gastrointestinal, genitourinary, lymphoid and pulmonary cancers |
Country Status (6)
| Country | Link |
|---|---|
| AR (1) | AR053576A1 (fr) |
| GT (1) | GT200600147A (fr) |
| PE (1) | PE20061361A1 (fr) |
| TW (1) | TW200719914A (fr) |
| UY (1) | UY29471A1 (fr) |
| WO (1) | WO2006113172A1 (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0610925D0 (en) * | 2006-06-02 | 2006-07-12 | Novartis Ag | Use of vascular endothelial growth factor receptor inhibitors for the treatment of cancer |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CO4950519A1 (es) * | 1997-02-13 | 2000-09-01 | Novartis Ag | Ftalazinas, preparaciones farmaceuticas que las comprenden y proceso para su preparacion |
-
2006
- 2006-04-10 GT GT200600147A patent/GT200600147A/es unknown
- 2006-04-10 WO PCT/US2006/013056 patent/WO2006113172A1/fr not_active Ceased
- 2006-04-11 UY UY29471A patent/UY29471A1/es not_active Application Discontinuation
- 2006-04-11 AR ARP060101427A patent/AR053576A1/es not_active Application Discontinuation
- 2006-04-12 TW TW095113028A patent/TW200719914A/zh unknown
- 2006-04-17 PE PE2006000398A patent/PE20061361A1/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AR053576A1 (es) | 2007-05-09 |
| WO2006113172A1 (fr) | 2006-10-26 |
| GT200600147A (es) | 2006-11-24 |
| UY29471A1 (es) | 2006-11-30 |
| PE20061361A1 (es) | 2007-01-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UA99833C2 (en) | Pyrimidinyl pyridazinone derivates | |
| MX2009008222A (es) | Antagonistas de activina-actriia y usos para tratar o prevenir cancer de mama. | |
| CL2007002062A1 (es) | Compuestos derivado de [1,2,4]triazolo[4,3-a]piridina, inhibidores de quinasa; composicion farmaceutica; y su uso en el tratamiento del cancer. | |
| GEP20125664B (en) | Condensed heterocyclic derivatives and application thereof | |
| TW200833684A (en) | 5,6-ring annulated indole derivatives and methods of use thereof | |
| IL186104A0 (en) | Phosphoramidate derivatives of nucleoside compounds for use in the treatment of cancer | |
| TN2010000236A1 (en) | Fused pyridine pyrimidine and triazine compounds as cell cycle inhibitors | |
| MX355632B (es) | Inhibidores de la trayectoria de señalización notch y uso de los mismos en el tratamiento de cánceres. | |
| TW200833662A (en) | 4,5-ring annulated indole derivatives and methods of use thereof | |
| JO3134B1 (ar) | مثبطات نشاط akt | |
| HRP20080377A2 (en) | ACTIVIN ActRIIa ANTAGONISTS AND USES FOR PROMOTING BONE GROWTH | |
| MX2009008698A (es) | Arabinoxilo-oligosacaridos en cerveza. | |
| WO2008015383A3 (fr) | Activité anticancéreuse des protéines bmp-9 et bmp-10 et leur utilisation dans les traitements du cancer | |
| MY173616A (en) | Compositions and methods for lowering triglycerides | |
| MXPA05011353A (es) | Compuestos heterociclicos que se unen al receptor de quimiocina con eficacia mejorada. | |
| PL2173337T3 (pl) | Fosfaplatyny i ich zastosowanie w leczeniu raków opornych na cisplatynę i karboplatynę | |
| MX2011006725A (es) | Combinacion de inhibidores de aurora cinasa y anticuerpos anti-cd20. | |
| SG171583A1 (en) | Composition for the treatment of resistant cancers comprising oridonin | |
| MX2009001516A (es) | Aplicacion por via transdermica de triazinas para combatir infecciones por coccidios. | |
| MX2011007165A (es) | Derivados de piridazinona. | |
| IL196825A0 (en) | Methods, compositions and articles of manufacture for contributing to the treatment of cancers | |
| MX2009004436A (es) | Derivados de quinazolina macrociclicos como inhibidores del factor de crecimiento endotelial vascular r3. | |
| WO2008033887A8 (fr) | Procédés de traitement du cancer | |
| MX2010004259A (es) | Tratamientos antitumorales mejorados. | |
| TW200719914A (en) | Use of vascular endothelial growth factor receptor inhibitors for the treatment of gastrointestinal, genitourinary, lymphoid and pulmonary cancers |